Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Monday. Several other research firms have ...
The TOP10 of the Green500 includes three Eviden-built systems that all use Eviden's unique Direct Liquid Cooling technology - an in-house patented solution to cool the entire supercomputer using warm ...
Some results have been hidden because they may be inaccessible to you